(NOTE: This talk was given in 2009, and this field of science has developed quickly since then. Read "Corrections & Updates" below for more details.) Drug-resistant bacteria kills, even in top hospitals. But now tough infections like staph and anthrax may be in for a surprise. Nobel-winning chemist Kary Mullis, who watched a friend die when powerful antibiotics failed, unveils a radical new cure that shows extraordinary promise.

Kary Mullis: A next-gen cure for killer infections

A next-gen cure for killer infections

Utilizing alpha-gal to essentially 'tag' harmful bacteria, enabling quick identification and eradication by the immune system.

A groundbreaking experiment shows 100% survival in mice treated against anthrax, marking a potential victory against deadly infections.

Harnessing alpha-gal epitope, a molecule, to redirect immune responses, offers a promising path against resistant bacteria.